Nature's Way, Umcka ColdCare, Children's, Cherry Flavor Syrup, 4 fl oz (120 ml) Сладкий сироп приятного вишнёвого вкуса.
Основной компонент - Pelargonium sidoides (один из видов герани).
Важно начать применение при первых признаках простуды.
Нам нравится эффект (прошли начинающийся насморк и боль в горле).
Children 12 years of age and older
Take 1.5 teaspoons (7.5 ml) three times daily
Children 6-11 years of age
Take 1 teaspoon (5 ml) three times daily
Раздел Nature's Way, Umcka, ColdCare Читайте о противопоказаниях и советуйтесь с врачом.
Из описания препарата Умкалор (Umkalor), содержащего данное растение
"Основными действующими веществами экстракта корня Pelargonium sidoides являются кумарины, флавонолы и органические кислоты, которые обладают бактерицидной и бактериостатической активность против следующих штаммов микроорганизмов: Грамположительные бактерии, в том числе Staphylococcus aureus, Streptococcus haemolitic, Streptococcus pneumoniae; Грамотрицательных бактерий, в том числе Hemophilus influenzae, Klebsiella pneumoniae, Proteus mirabillis, Pseudomonas aeruginosa, E.coli; Препарат также активен относительно микроорганизмов штамма Mycobacterlum tuberculosis. Активные вещества препарата влияют на иммунную систему, активизируя одновременно механизмы специфического и неспецифического иммунитета.
Препарат применяют при острых и хронических инфекционных заболеваниях вызванных микроорганизмами чувствительными к действующим веществам препарата, в том числе:
Острые и хронические заболевания верхних дыхательных путей: острый и хронический бронхит, острый и хронический фарингит, трахеит.
Острые и хронические заболевания ЛОР-органов: синуситы (в том числе гайморит, фронтит, этмоидит, сфеноидит), ангина, ринофарингит, отит.
http://www.piluli.kharkov.ua/drugs/drug/umkalor Исследования
This was a multicenter, prospective, double-blind, placebo-controlled randomized trial to evaluate the effectiveness of a liquid herbal preparation from the roots of Pelargonium sidoides for decreasing the duration and severity of symptoms of the common cold.
Patient characteristics. Patients were recruited from 8 outpatient departments in Ukraine between December 2003 and May 2004. Two hundred and seven (207) patients were eligible. The number of ineligible and excluded patients was not stated. These 207 patients were randomized into 1 of 4 groups:
52 received 30 drops 3 times daily vs 51 patients who received placebo
52 patients received 60 drops 3 times daily vs 52 patients who received a higher-dose placebo.
To get the benefits, treatment must start early. Patients could be advised to buy the medication, to have on hand
This is the first study that demonstrates the efficacy and safety of P sidoides in the treatment of the common cold. More importantly, this degree of improvement in cold symptoms is dramatically better than other common OTC treatments, including vitamin C, echinacea, and zinc preparations.
www.ncbi.nlm.nih.gov The aim of the present study was to evaluate the efficacy of a liquid herbal drug preparation from the roots of Pelargonium sidoides compared with placebo in adult patients with the common cold.
Treatment outcome (rates of complete recovery or major improvement from disease [integrative medicine outcomes scale]) was assessed better in the EPs treatment group than in the placebo group by both the investigator and the patient on day five (P < .0001). Adverse events occurred in three of 103 patients (2.9%), with two of 52 (3.8%) and one of 51 (2.0%) patients in the EPs and placebo group, respectively. All adverse events were assessed as nonserious. At the end of treatment, all patients (100%) in the active treatment group judged the subjective tolerability of EPs as good or very good.
CONCLUSIONS:
EPs represents an effective treatment of the common cold. It significantly reduces the severity of symptoms and shortens the duration of the common cold compared with placebo. The herbal drug is well tolerated.
www.ncbi.nlm.nih.gov Витамины и БАДы для детей (iHerb) iHerb и БАДы простудного периода